Article X/Twitter March 5, 2026
Ozempic may reduce the mortality risk from colon cancer — GLP-1 users were less than half as likely to die within 5 years

AI Summary
🐦 **Trending on X: More Than Just Weight Loss!** Dr. Rhonda Patrick dropped some groundbreaking news, showing GLP-1s like Ozempic might slash colon cancer mortality risk by over 50%! This isn't just about the scale, folks; it's a powerful reminder of the deep, systemic health benefits these medications can offer for our long-term well-being.
Dr. Rhonda Patrick shared new research showing GLP-1 drugs (Ozempic, Wegovy, Mounjaro) may specifically target obesity-driven inflammatory pathways, reducing colon cancer mortality by more than 50%.
Related Articles
Gila is coming to iPhone and Android
Your doses, meals, habits and food noise in one daily timeline. Join the waitlist and we’ll email you when it’s on your phone.
Join the waitlist